Literature DB >> 2129154

Thiol-containing cross-linking agent with enhanced steric hindrance.

L Greenfield1, W Bloch, M Moreland.   

Abstract

Ricin A chain immunotoxins disulfide cross-linked with conventional, sterically unhindered reagents have unsatisfactorily short circulating life times in vivo. (Acetylthio)succinic anhydride, a thiolating reagent with partial steric hindrance of the sulfur atom, does not remedy this situation. Sulfosuccinimidyl N-[3-(acetylthio)-3-methylbutyryl]-beta- alaninate, a new cross-linker in which the carbon alpha to the sulfur is doubly methylated, creates disulfide bonds 2 orders of magnitude more resistant to reduction than unhindered disulfides. Nevertheless, this deactivated thiolating agent rapidly and reliably cross-links ricin A chain and antibodies to create immunotoxins with in vitro cytotoxicities comparable to those of 2-iminothiolane-coupled conjugates.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2129154     DOI: 10.1021/bc00006a006

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  4 in total

1.  Structural effect on degradability and in vivo contrast enhancement of polydisulfide Gd(III) complexes as biodegradable macromolecular MRI contrast agents.

Authors:  Yuda Zong; Xuli Wang; Eun-Kee Jeong; Dennis L Parker; Zheng-Rong Lu
Journal:  Magn Reson Imaging       Date:  2008-09-23       Impact factor: 2.546

2.  Chemically crosslinked protein dimers: stability and denaturation effects.

Authors:  M P Byrne; W E Stites
Journal:  Protein Sci       Date:  1995-12       Impact factor: 6.725

3.  Iterative Reducible Ligation to form Homogeneous Penicillamine Cross-linked Polypeptides.

Authors:  Mark D Ericson; Kevin G Rice
Journal:  Tetrahedron Lett       Date:  2013-06-26       Impact factor: 2.415

Review 4.  Immunotoxins and anticancer drug conjugate assemblies: the role of the linkage between components.

Authors:  Franco Dosio; Paola Brusa; Luigi Cattel
Journal:  Toxins (Basel)       Date:  2011-07-14       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.